RapiGEN BIOCREDIT Malaria Ag RDTs WHO Prequalification Study

CompletedOBSERVATIONAL
Enrollment

674

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

May 30, 2022

Study Completion Date

May 30, 2023

Conditions
MalariaDiagnoses DiseaseRDT
Interventions
DIAGNOSTIC_TEST

Rapid diagnostic test

The performance of three index tests and two comparator tests will be compared to reference tests and gold standard microscopy.

Trial Locations (2)

10430

Eijkman Institute for Molecular Biology, Jakarta

Unknown

Institute of Endemic Diseases, Medical Campus, Khartoum

All Listed Sponsors
collaborator

University of Khartoum

OTHER

collaborator

Eijkman Institute for Molecular Biology

OTHER

lead

Foundation for Innovative New Diagnostics, Switzerland

OTHER

NCT05085301 - RapiGEN BIOCREDIT Malaria Ag RDTs WHO Prequalification Study | Biotech Hunter | Biotech Hunter